McKinseymedium engagement
McKinsey partner questions and pay talk keep heating up
A mix of social discussion about McKinsey career structure and compensation, plus an insider transaction linked to a person named Kearney, keeps the consulting ecosystem visible. The discussion centers on how partner roles work, whether senior partners stay hands-on, and what compensation looks like in top-tier consulting.
Draft a post from this →clinical trialsmedium engagement
Biopharma trials keep moving across autoimmune and cancer pipelines
Several clinical-trial updates show active and suspended programs in autoimmune disease, inflammatory myopathies, ulcerative colitis, osteosarcoma, and chordoma. While not consulting directly, these programs are the kind of healthcare R&D activity that often drives strategy, portfolio, and commercial advisory work for life-sciences clients.
Draft a post from this →NIH grantslow engagement
NIH funding keeps research infrastructure and trials moving
NIH and related funding notices highlight grants for data infrastructure, senolytic cancer research, suicide-risk interventions, and receptor-targeting work. This is a lower-direct-relevance but useful context stream for strategy advisors covering healthcare, public-sector, and research-intensive clients.
Draft a post from this →